Combining effects of one tumor-stroma recognizing TCR with one cancer‑cell specific TCR for eradication of solid tumors
- Alternative title
-
Kombination von einnem TCR der das Tumorstroma erkennt mit einem TCR der Krebszellspezifisch ist für die Behandlung von soliden Tumoren
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Berlin, Freie Universität Berlin, Dissertation, 2020
- Keyword
-
Tumors
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Freie Universität Berlin
- (when)
-
2021
- Creator
- DOI
-
10.17169/refubium-28670
- URN
-
urn:nbn:de:kobv:188-refubium-28921-4
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wolf, Steven Patrick
- Freie Universität Berlin
Time of origin
- 2021
Other Objects (12)
TCR engineered T cells for solid tumor immunotherapy
TcR
Ko-Tests: TCR
Natalizumab alters the TCR repertoire after one year of treatment in four MS patients
Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions
The identification of effective tumor-suppressing neoantigens using a tumor-reactive TIL TCR-pMHC ternary complex
HeteroTCR: A heterogeneous graph neural network-based method for predicting peptide-TCR interaction
Die Variabilität des Ratten iNKT TCR : = The variability of the rat iNKT TCR
Cross-TCR antagonism revealed by optogenetically tuning the half-life of the TCR ligand binding
TCR-like antibodies in cancer immunotherapy
TUMOR onE WU!
Evaluation of TCR amplification in tumor lesions and peripheral blood of renal cell carcinoma patients
TCR engineered T cells for solid tumor immunotherapy
TcR
Ko-Tests: TCR
Natalizumab alters the TCR repertoire after one year of treatment in four MS patients
Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions
The identification of effective tumor-suppressing neoantigens using a tumor-reactive TIL TCR-pMHC ternary complex
HeteroTCR: A heterogeneous graph neural network-based method for predicting peptide-TCR interaction
Die Variabilität des Ratten iNKT TCR : = The variability of the rat iNKT TCR
Cross-TCR antagonism revealed by optogenetically tuning the half-life of the TCR ligand binding
TCR-like antibodies in cancer immunotherapy
TUMOR onE WU!
Evaluation of TCR amplification in tumor lesions and peripheral blood of renal cell carcinoma patients
TCR engineered T cells for solid tumor immunotherapy
TcR
Ko-Tests: TCR
Natalizumab alters the TCR repertoire after one year of treatment in four MS patients
Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions
The identification of effective tumor-suppressing neoantigens using a tumor-reactive TIL TCR-pMHC ternary complex
HeteroTCR: A heterogeneous graph neural network-based method for predicting peptide-TCR interaction
Die Variabilität des Ratten iNKT TCR : = The variability of the rat iNKT TCR
Cross-TCR antagonism revealed by optogenetically tuning the half-life of the TCR ligand binding
TCR-like antibodies in cancer immunotherapy
TUMOR onE WU!